FREE SHIPPING!* Flowflex™ Covid-19 Antigen Home Test, 300 Tests ($3.99 per test~1 Case)

*FREE GROUND SHIPPING!* Simply choose “Free Ground” in checkout when the FlowFlex™ test is in your cart!

300 Tests per Case ($3.99 per test).

The Flowflex^™ COVID-19 Antigen Home Test is all you need to determine your family’s Covid-19 status, whether symptoms are present or not.

This is a rapid, reliable test for the detection of SARS-CoV-2 antigens in anterior nasal specimens.

No prescription or insurance required! This affordable, safe, at home self-test is simple to use and can be used on children as young as 2 years old.

Get the convenience of Flowflex!

• Easy and Affordable
• Highly Accurate, Easy-to-use Nasal Swab Test
• Quick Results in 15 minutes
• Safe for children as young as 2 years old
• For use with and without COVID-19 symptoms

Flowflex Covid-19 Antigen Home Test Sales Sheet

Flowflex Covid-19 Antigen Home Test Consumer Package Insert- English

Flowflex Covid-19 Antigen Home Test Consumer Package Insert- Spanish

Flowflex Covid-19 Antigen Home Test FDA EUA Letter Approval

Flowflex Covid-19 Antigen Home Test Healthcare Providers Package Insert- English

Flowflex Covid-19 Antigen Home Test Fact Sheet Healthcare Professionals

Flowflex Covid-19 Antigen Home Test FAQ

Flowflex Covid-19 Antigen Home Test Safety Data Sheet

This test uses a nasal swab sample to determine the presence or absence of COVID-19 antigens in nasal samples. For a demonstration on how this test works, watch the instructional video.

• This product has not been been FDA cleared or approved; but has been authorized by FDA under an EUA; https://www.fda.gov/media/152700/download 
• This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; and,
• This product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. 360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner.

For more information on EUAs please visit: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization

For the most up to date information on COVID-19, please visit: www.cdc.gov/COVID19